OPU
CNST

Omni Partners US’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Omni Partners US’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,815,117
Closed -$61.4M – 293
2021
Q2 		$61.4M Buy
+1,815,117
New +$46.3M 2.7% 11

Omni Partners US's CNST Position: Q3 2021 in Review

Omni Partners US sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,815,117 shares — an estimated $61.4M sold.

Omni Partners US first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $61.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Omni Partners US reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Omni Partners US sold 1,815,117 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $61.4M.
  • Omni Partners US first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Omni Partners US's Constellation Pharmaceuticals, Inc. position peaked at $61.4M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.